Brain Tumors

Latest Articles

2008 to 2017 Saw Decrease in Malignant Brain Tumor Incidence

From 2008 to 2017, the incidence of malignant brain tumors decreased for all ages combined, but increased among children and adolescents.

Predictive Models for Clinical Characteristics Linked to Pediatric Neurofibromatosis Type 1

Researchers applied a machine learning strategy in a longitudinal analysis of clinical features linked to neurofibromatosis type 1 in pediatric patients.

Very Elderly Can Benefit From Brain Tumor Surgery

Surgical treatment of intracranial meningioma (IM) should be considered even in patients over the age of 80 years.

Patients in Bind as Brain Cancer Drug Price Rises to $1,000 Per Pill

The maker of the expensive brain cancer drug Gleostine has removed it from the Medicare drug rebate program.

Combination Immunotherapy Effective for Patients With Melanoma and Asymptomatic Brain Metastases

The combination of nivolumab with ipilimumab is an effective treatment option for patients with advanced melanoma with asymptomatic brain metastases

Occult Brain Metastasis Detected in Patients With Advanced Renal Cancer

Occult brain metastasis is identified in about 4 percent of patients with metastatic renal cell carcinoma (mRCC).

Socioeconomics Tied to Cognitive Function in Survivors of Childhood Brain Tumors

Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.

Risk Factors for Seizure Development Among Patients With Brain Metastases

Study researchers evaluated the incidence and risk factors for seizure development among patients with brain metastases.

Incidence of VTE, Major Bleeding High in Primary CNS Lymphoma

The incidence of venous thromboembolism and major bleeding is high among patients with primary central nervous system lymphoma.

FDA Grants Orphan Drug Status to Berubicin for Malignant Gliomas

Findings from the study showed 44% of patients treated with berubicin experienced a statistically significant improvement in progression free survival.